
Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring blaNDM and blaOXA From Clinical Origin
Author(s) -
Hasan Ejaz,
Muhammad Muneeb Ahmad,
Sonia Younas,
Kashaf Junaid,
Khalid Omer Abdalla Abosalif,
Abualgasim Elgaili Abdalla,
Ayman Ali Mohammed Alameen,
Mohammed Yagoub Mohammed Elamir,
Syed Nasir Abbas Bukhari,
Naveed Ahmad,
Muhammad Usman Qamar
Publication year - 2021
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s310478
Subject(s) - acinetobacter baumannii , colistin , microbiology and biotechnology , multilocus sequence typing , biology , antibiotics , drug resistance , antimicrobial , antibiotic resistance , molecular epidemiology , genotype , bacteria , gene , genetics , pseudomonas aeruginosa
The therapeutic management of carbapenem-resistant Acinetobacter baumannii (CR-AB) represents a serious challenge to the public health sector because these pathogens are resistant to a wide range of antibiotics, resulting in limited treatment options. The present study was planned to investigate the clonal spread of CR-AB in a clinical setting.